SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17323789
Source:
http://linkedlifedata.com/resource/pubmed/id/17323789
Search
Subject
(
68
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0036667
,
umls-concept:C0043157
,
umls-concept:C0078988
,
umls-concept:C0220938
,
umls-concept:C0312418
,
umls-concept:C0680174
,
umls-concept:C0681850
,
umls-concept:C1550501
,
umls-concept:C1699926
,
umls-concept:C1706203
,
umls-concept:C2349001
,
umls-concept:C2603343
,
umls-concept:C2697811
pubmed:issue
2
pubmed:dateCreated
2007-2-27
pubmed:abstractText
The authors compared the pharmacokinetics and pharmacological effects of the immunomodulator fingolimod in healthy white and Asian subjects for potential ethnic differences.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9423309
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Propylene Glycols
,
http://linkedlifedata.com/resource/pubmed/chemical/Sphingosine
,
http://linkedlifedata.com/resource/pubmed/chemical/fingolimod
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0946-1965
pubmed:author
pubmed-author:KawaiRR
,
pubmed-author:KovarikJ MJM
,
pubmed-author:Mee-LeeDD
,
pubmed-author:PicardFF
,
pubmed-author:RiviereG JGJ
,
pubmed-author:SchmidliHH
,
pubmed-author:SchmouderR LRL
,
pubmed-author:SladeAA
,
pubmed-author:SugitaYY
,
pubmed-author:VostAA
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
98-109
pubmed:dateRevised
2008-6-5
pubmed:meshHeading
pubmed-meshheading:17323789-Area Under Curve
,
pubmed-meshheading:17323789-Asian Continental Ancestry Group
,
pubmed-meshheading:17323789-Dose-Response Relationship, Drug
,
pubmed-meshheading:17323789-Double-Blind Method
,
pubmed-meshheading:17323789-Drug Administration Schedule
,
pubmed-meshheading:17323789-European Continental Ancestry Group
,
pubmed-meshheading:17323789-Female
,
pubmed-meshheading:17323789-Heart Rate
,
pubmed-meshheading:17323789-Humans
,
pubmed-meshheading:17323789-Immunosuppressive Agents
,
pubmed-meshheading:17323789-Lymphocyte Count
,
pubmed-meshheading:17323789-Lymphocytes
,
pubmed-meshheading:17323789-Male
,
pubmed-meshheading:17323789-Metabolic Clearance Rate
,
pubmed-meshheading:17323789-Metabolic Detoxication, Drug
,
pubmed-meshheading:17323789-Propylene Glycols
,
pubmed-meshheading:17323789-Sphingosine
pubmed:year
2007
pubmed:articleTitle
Ethnic sensitivity study of fingolimod in white and Asian subjects.
pubmed:affiliation
Novartis Pharmaceuticals, Basle, Switzerland. john.kovarik@Novartis.com
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II
,
Clinical Trial, Phase I